It is a GLP-1 (glucagon-like peptide-1) receptor agonist used for maintaining blood glucose levels in patients with type 2 diabetes and weight loss management in people with obesity or overweight when used in combination with exercise and dietary changes
Symptoms include fast heartbeat, shaking, sweating, nervousness or anxiety, irritability or confusion and dizziness
Freezing can irreversibly damage semaglutides molecular structure
The active ingredient in Ozempic is semaglutide, a GLP-1 receptor agonist, and it also contains inactive ingredients such as sodium chloride, disodium phosphate, and water for injection, which help stabilize the formulation for subcutaneous use
These changes can increase sensitivity to gastric irritation, potentially triggering involuntary diaphragm contractions
Resistance exercise can help preserve function and lean tissue during weight reduction